Oxycodone Hydrochloride 10mg/ml Oral Solution Malta - engelsk - Medicines Authority

oxycodone hydrochloride 10mg/ml oral solution

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - oxycodone hydrochloride - oral solution - oxycodone hydrochloride 10 mg/ml - analgesics

Oxycodone Hydrochloride 5mg/5ml Oral Solution Malta - engelsk - Medicines Authority

oxycodone hydrochloride 5mg/5ml oral solution

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - oxycodone hydrochloride - oral solution - oxycodone hydrochloride 5 mg/5ml - analgesics

Oxycodone Hydrochloride 10 mg/ml Solution for Injection or Infusion - 2ml vial Malta - engelsk - Medicines Authority

oxycodone hydrochloride 10 mg/ml solution for injection or infusion - 2ml vial

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - oxycodone hydrochloride - solution for injection/infusion - oxycodone hydrochloride 10 mg/ml - analgesics

SUBOXONE FILM 4/1 buprenorphine (as hydrochloride) 4 mg/naloxone (as hydrochloride dihydrate) 1 mg soluble film sachet Australia - engelsk - Department of Health (Therapeutic Goods Administration)

suboxone film 4/1 buprenorphine (as hydrochloride) 4 mg/naloxone (as hydrochloride dihydrate) 1 mg soluble film sachet

indivior pty ltd - buprenorphine hydrochloride, quantity: 4.32 mg (equivalent: buprenorphine, qty 4 mg); naloxone hydrochloride dihydrate, quantity: 1.22 mg (equivalent: naloxone, qty 1 mg) - soluble film - excipient ingredients: acesulfame potassium; citric acid; maltitol solution; hypromellose; polyethylene oxide; sodium citrate; sunset yellow fcf; flavour; titanium dioxide; propylene glycol; purified water; industrial methylated spirit - treatment of opiate dependence within a framework of medical, social, and pyschological treatment.

OXYCODONE AND ASPIRIN tablet USA - engelsk - NLM (National Library of Medicine)

oxycodone and aspirin tablet

actavis pharma, inc. - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) - oxycodone hydrochloride 4.8355 mg - oxycodone and aspirin tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses (see warnings), reserve oxycodone and aspirin tablets for use in patients for whom alternative treatment options (e.g., non- opioid analgesics) - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia oxycodone and aspirin tablets are contraindicated in patients with: - significant respiratory depression (see warnings) - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment (see warnings) - known or suspected gastrointestinal obstruction, including paralytic ileus (see warnings) - hypersensitivity to oxycodone or aspirin, (e.g. angioedema) (see warnings) - patients with hemophilia. - aspi

OXYCODONE HCL CONTROLLED-RELEASE tablet
OXYCODONE HCL CONTROLLED-RELEASE tablet USA - engelsk - NLM (National Library of Medicine)

oxycodone hcl controlled-release tablet oxycodone hcl controlled-release tablet

ranbaxy pharmaceuticals inc - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570) - oxycodone hydrochloride 10 mg - oxycodone hcl controlled-release tablets are a controlled-release oral formulation of oxycodone hydrochloride indicated for the management of moderate to severe pain when a continuous, around-the-clock analgesic is needed for an extended period of time. oxycodone hcl controlled-release tablets are not intended for use as a prn analgesic. physicians should individualize treatment in every case, initiating therapy at the appropriate point along a progression from non-opioid analgesics, such as non-steroidal anti-inflammatory drugs and acetaminophen to opioids in a plan of pain management such as outlined by the world health organization, the agency for healthcare research and quality (formerly known as the agency for health care policy and research), the federation of state medical boards model guidelines, or the american pain society. oxycodone hcl controlled-release tablets are not indicated for pain in the immediate postoperative period (the first 12-24 hours following surgery), or if the pain is mild, or n

OXYCODONE AND ACETAMINOPHEN tablet USA - engelsk - NLM (National Library of Medicine)

oxycodone and acetaminophen tablet

apotheca, inc - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - oxycodone hydrochloride 5 mg -   oxycodone and acetaminophen tablets are indicated for the relief of moderate to moderately severe pain. oxycodone and acetaminophen tablets should not be administered to patients with known hypersensitivity to oxycodone, acetaminophen, or any other component of this product. oxycodone is contraindicated in any situation where opioids are contraindicated including patients with significant respiratory depression (in unmonitored settings or the absence of resuscitative equipment) and patients with acute or severe bronchial asthma or hypercarbia. oxycodone is contraindicated in the setting of suspected or known paralytic ileus. oxycodone and acetaminophen tablets are a schedule ii controlled substance. oxycodone is a mu-agonist opioid with an abuse liability similar to morphine. oxycodone, like morphine and other opioids used in analgesia, can be abused and is subject to criminal diversion. drug addiction is defined as an abnormal, compulsive use, use for non-medical purposes of a substance despite physical, p

OXYCODONE HYDROCHLORIDE tablet USA - engelsk - NLM (National Library of Medicine)

oxycodone hydrochloride tablet

major pharmaceuticals - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570) - oxycodone hydrochloride tablets, usp, are an immediate-release oral formulation of oxycodone hydrochloride indicated for the management of moderate to severe pain where the use of an opioid analgesic is appropriate. oxycodone hydrochloride tablets are contraindicated in patients with known hypersensitivity to oxycodone, or in any situation where opioids are contraindicated. this includes patients with significant respiratory depression (in unmonitored settings or the absence of resuscitative equipment) and patients with acute or severe bronchial asthma or hypercarbia. oxycodone hydrochloride tablets is contraindicated in any patient who has or is suspected of having paralytic ileus. oxycodone hydrochloride tablets contains oxycodone, a mu-agonist opioid of the morphine type and is a schedule ii controlled substance . oxycodone hydrochloride tablets, like other opioids used in analgesia, can be abused and is subject to criminal diversion. drug addiction is characterized by compulsive use, use for non-medical p

Oxycodone Hydrochloride Solution for Inj/Inf 10mg/ml - 1ml vial Malta - engelsk - Medicines Authority

oxycodone hydrochloride solution for inj/inf 10mg/ml - 1ml vial

wockhardt uk limited - oxycodone hydrochloride - solution for infusion or injection - oxycodone hydrochloride 10 mg/ml - analgesics

Oxycodone Hydrochloride 5mg/5ml Oral Solution Malta - engelsk - Medicines Authority

oxycodone hydrochloride 5mg/5ml oral solution

wockhardt uk limited - oxycodone hydrochloride - oral solution - oxycodone hydrochloride 5 mg/5ml - analgesics